Renewal checkout

TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG

Serial No. 90318619

Owner
Genentech, Inc.
Status date
Oct 5, 2021

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG trademark drawing

USPTO record

Preparing this trademark

Serial 90318619. Checking the latest USPTO record. This usually takes a few seconds.

Public reviews

Client reviews

Public Google reviews of CopyMark Law Group.

Loading reviews…

Recent filings

Registered trademarks